Info

HealthChangers

On the HealthChangers podcast, presented by Regence, we share real-life stories and expertise from leaders who are working to make health care simpler, personalized and more affordable.
RSS Feed Subscribe in Apple Podcasts
HealthChangers
2024
July
May
April
March
February
January


2023
May
April
March
February
January


2022
December
July
May


2021
June
March
February
January


2020
December
September
August
July
June
May
April
March
February
January


2019
December
November
October
August
June
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February


2017
December
November
October
August
July
June
May
April
March


All Episodes
Archives
Now displaying: Page 1
May 2, 2020

The Cambia Grove helps drive the development of new solutions for health care. The industry-specific hub has been convening the health care community for the past two years, providing a point of connection for Cascadia’s innovators and catalyzing action.

As a reflection of the Cambia Grove’s growing role, reputation and visibility in our community, Cambia Grove’s Co-founder and Executive Director, Nicole Bell, was recently selected to serve as one of five judges nationally at the Alexa Diabetes Challenge—an international competition looking for comprehensive solutions that use Alexa’s voice technology to improve the experience of those who have been newly diagnosed with Type 2 Diabetes.

“I’m excited to be a judge because of what this technology represents for our industry,” said Bell. “This concept is about engaging people where they’re at, using a technology with a very low barrier to entry to give them a way to manage their care on their own terms and in their own homes.”

Nicole recently sat down with the Cambia Grove’s Community Executive, David Shepard, for a brief conversation about what​ the honor of being selected as a judge means to her, the Cambia Grove and Cambia. You can listen to the pop-up podcast here (eight minutes in length).

0 Comments
Adding comments is not available at this time.